Is Woodford Patient Capital revamp enough to lure back buyers?
Shares still not a 'buy'
Neil Woodford of Woodford Investment Management
The overhaul of Woodford Patient Capital trust's (WPCT) board must go even further, according to industry commentators, as brokers continue to urge investors to think carefully about snapping up shares despite its 32% discount to net asset value (NAV).
The board of WPCT moved to address the concerns of key shareholders on Friday (28 June) by announcing a raft of measures in response to the ongoing crisis at Woodford Investment Management. Amongst...
More on Investment Trusts
Most read
Back to Top